Imminent deals for 100,000 sq ft (9,290 sq m) of Cambridge business parks have sparked optimism in the beleaguered market.
US pharmaceutical company Genzyme is set to take 50,000 sq ft (4,645 sq m) in Xenova's building on Cambridge Science
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
